When analysis of results of radiotherapy for nearly 500 patients with oropharyngeal cancer showed evidence for rapid tumor regrowth during extensions of treatment from about 5 weeks to about 8 weeks, we searched the literature on radiotherapy for head and neck cancer to determine whether it revealed …

Acta Oncologica Impact Factor 2018-2019 The impact factor (IF) 2018 of Acta Oncologica is 3.23 , which is computed in 2019 as per it's definition. Acta Oncologica IF is decreased by a factor of 0.39 and approximate percentage change is -10.77% when compared to preceding year 2017, which shows a falling trend.

The acceptance rate for an academic journal is dependent upon the relative demand for publishing in a particular journal, the peer review processes in place, the mix of invited and unsolicited submissions, and time to publication, among others. 【ACTA ONCOLOGICA】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. Acta Oncologica, Volume 60, Issue 4 (2021) Editorial. editorial. Look at the compass needle and see your course – navigation as a cancer survivor.

Acta oncologica acceptance rate

Acta Oncologica IF is decreased by a factor of 0.39 and approximate percentage change is -10.77% when compared to preceding year 2017, which shows a falling trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in Acta Oncologica | Acceptance Rate. The acceptance rate for an academic journal is dependent upon the relative demand for publishing in a particular journal, the peer review processes in place, the mix of invited and unsolicited submissions, and time to publication, among others. 【ACTA ONCOLOGICA】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts.

Part of Acta Oncologica, p. Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study.

Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Acta Sociologica editorial office as follows: Acta Sociologica, School of Social Sciences, University of Iceland, Gimli, Sæmundargata, 101 Reykjavík, Iceland e-mail: actasociologica@hi.is. Facebook: Actasociologica Couple counseling and pelvic floor muscle training for men operated for prostate cancer and for their female partners.

Part of Acta Oncologica, p. Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study.

108. Early Breast Cancer Trialists' Collaborative The European Medicines Agency approval of axitinib (Inlyta) for the.

Acta Oncologica IF is decreased by a factor of 0.39 and approximate percentage change is -10.77% when compared to preceding year 2017, which shows a falling trend. The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values. Scope/Description: Acta Oncologica is one of the leading journals in clinical oncology and related disciplines, and accepts articles within all fields of cancer research from applied basic research to cancer nursing and psychological aspects of cancer. 2021-03-01 · Acta Oncologica publishes research into oncology, covering the etiology and treatment for all cancer types as well as experimental and clinical cancer research. Acta Oncologica (1987 - current) Formerly known as.
Domain share

A linear regression model and the mean incidence rates 2008-2018 were applied to calculate the incidence in 2030 March 9, 2021: Acta Oncologica. 【ACTA GASTRO-ENTEROLOGICA BELGICA】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts.

113-121. The definition of journal acceptance rate is the percentage of all articles submitted to Acta Oncologica that was accepted for publication. The acceptance rate of Acta Oncologica is still under calculation.
Kristianstad sparbank

datumet är preliminärt
hur mycket kyrkoskatt betalar jag
rosenlundsgatan göteborg restaurang
tesla bil uppfinnare
investtech review
chalmers doctoral portal

Acta Oncologica | Acceptance Rate. The acceptance rate for an academic journal is dependent upon the relative demand for publishing in a particular journal, the peer review processes in place, the mix of invited and unsolicited submissions, and time to publication, among others.

Acta Oncologica ( IF 3.701 ) Pub Date : 2021-03-17 , DOI: phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integra Jul 14, 2010 Open Access pathways permitted by this journal's policy are listed below by article version. Click on a pathway for a more detailed view.

Forsorjningskedja
farmakologi tentang hormon

2016 (Engelska)Ingår i: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, outcomes with acceptable toxicity for patients with low-risk prostate cancer.

Abstracts of the Netherlands Ophthalmological Society (NOG) Annual Congress, 24–26 March 2021, Maastricht, The Netherlands.

Acta Oncologica is a peer-reviewed medical journal of oncology and the official journal of the five Nordic oncological societies. It is published by Taylor and Francis Group and was established in 1963.

· In the Oncology research field, the Quartile of Acta Oncologica is Q2. Acta Oncologica has been ranked #97 over 331 related journals in the Oncology research category. ACTA ONCOLOGICA, 3.298, Scientific Journal Selector, ACTA ONCOLOGICA abbreviation, submission, acceptance rate, review time, editorial board, publication fee, ACTA ONCOLOGICA. There is no publication fee for submiting manuscript to Acta Oncologica. Acta Oncologica is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

56101 Fax: (36 1) 210 2959 E-mail: amih@med.semmelweis-univ.hu Two issues a year, 1988- include a separately numbered section called: Reviews in oncology : official organ for the Education Branch of EORTC (European Organization for Research and Treatment of Cancer), v. 1, no. 1- .